Givaudan Forecast, price target & analysts
Givaudan Target price 2025 - Analyst rating & recommendation
Givaudan Classifications & Recommendation:
Givaudan Price Target
| Target Price | CHF4,105.50 |
| Price | CHF3,411.00 |
| Potential | 20.36% |
| Number of Estimates | 25 |
| 25 Analysts have issued a price target Givaudan 2026 . The average Givaudan target price is CHF4,105.50. This is 20.36% higher than the current stock price. The highest price target is CHF5,040.00 47.76% , the lowest is CHF3,232.00 5.25% . | |
| A rating was issued by 29 analysts: 13 Analysts recommend Givaudan to buy, 13 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Givaudan stock has an average upside potential 2026 of 20.36% . Most analysts recommend the Givaudan stock at Buy or hold. |
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion CHF | 7.41 | 7.72 |
| 7.19% | 4.09% | |
| EBITDA Margin | 20.74% | 24.61% |
| 15.08% | 18.68% |
25 Analysts have issued a sales forecast Givaudan 2025 . The average Givaudan sales estimate is CHF7.7b . This is 2.33% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF8.3b 10.17% , the lowest is CHF7.3b 3.81% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | CHF7.4b | 7.19% |
|---|---|---|
| 2025 | CHF7.7b | 4.09% |
| 2026 | CHF8.0b | 3.93% |
| 2027 | CHF8.4b | 5.31% |
| 2028 | CHF9.1b | 7.96% |
| 2029 | CHF9.6b | 5.52% |
| 2030 | CHF10.0b | 4.38% |
| 2031 | CHF9.7b | 3.67% |
| 2032 | CHF9.9b | 2.84% |
24 Analysts have issued an Givaudan EBITDA forecast 2025. The average Givaudan EBITDA estimate is CHF1.9b . This is 20.96% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF2.0b 28.92% , the lowest is CHF1.6b 3.89% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | CHF1.5b | 23.35% |
|---|---|---|
| 2025 | CHF1.9b | 23.55% |
| 2026 | CHF2.0b | 4.90% |
| 2027 | CHF2.1b | 5.12% |
| 2028 | CHF2.2b | 4.20% |
| 2029 | CHF2.4b | 9.21% |
| 2030 | CHF2.6b | 7.93% |
EBITDA Margin
| 2024 | 20.74% | 15.08% |
|---|---|---|
| 2025 | 24.61% | 18.68% |
| 2026 | 24.84% | 0.93% |
| 2027 | 24.80% | 0.16% |
| 2028 | 23.94% | 3.47% |
| 2029 | 24.77% | 3.47% |
| 2030 | 25.62% | 3.43% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 117.63 | 129.57 |
| 21.93% | 10.15% | |
| P/E | 26.40 |
25 Analysts have issued a Givaudan forecast for earnings per share. The average Givaudan EPS is CHF129.57 . This is 9.81% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF141.60 20.01% , the lowest is CHF117.21 0.66% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | CHF117.63 | 21.93% |
|---|---|---|
| 2025 | CHF129.57 | 10.15% |
| 2026 | CHF135.26 | 4.39% |
| 2027 | CHF144.64 | 6.93% |
| 2028 | CHF156.18 | 7.98% |
| 2029 | CHF166.65 | 6.70% |
| 2030 | CHF181.08 | 8.66% |
P/E ratio
| Current | 28.99 | 26.71% |
|---|---|---|
| 2025 | 26.40 | 8.95% |
| 2026 | 25.29 | 4.20% |
| 2027 | 23.65 | 6.48% |
| 2028 | 21.90 | 7.40% |
| 2029 | 20.53 | 6.26% |
| 2030 | 18.89 | 7.99% |
Current Givaudan Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BAADER HELVEA EQUITY RESEARCH |
Buy
➜
Buy
|
Unchanged | Jul 13 2025 |
| BERENBERG |
Buy
➜
Buy
|
Unchanged | Jun 30 2025 |
| ESN/CIC MARKET SOLUTIONS |
Neutral
➜
Neutral
|
Unchanged | Jun 22 2025 |
| ROTHSCHILD & CO REDBURN |
Neutral
➜
Neutral
|
Unchanged | Jun 22 2025 |
| DAVY |
Neutral
➜
Neutral
|
Unchanged | Jun 18 2025 |
| JEFFERIES |
Underperform
➜
Underperform
|
Unchanged | Jun 17 2025 |
| DAY BY DAY |
Buy
➜
Buy
|
Unchanged | Jun 01 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
BAADER HELVEA EQUITY RESEARCH:
Buy
➜
Buy
|
Jul 13 2025 |
|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Jun 30 2025 |
|
Unchanged
ESN/CIC MARKET SOLUTIONS:
Neutral
➜
Neutral
|
Jun 22 2025 |
|
Unchanged
ROTHSCHILD & CO REDBURN:
Neutral
➜
Neutral
|
Jun 22 2025 |
|
Unchanged
DAVY:
Neutral
➜
Neutral
|
Jun 18 2025 |
|
Unchanged
JEFFERIES:
Underperform
➜
Underperform
|
Jun 17 2025 |
|
Unchanged
DAY BY DAY:
Buy
➜
Buy
|
Jun 01 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
